Peculiarities of the induction immunosuppressive therapy in renal transplantation
Open Access
- 30 December 2022
- journal article
- research article
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 89 (11-12) , 46-52
Abstract
Peculiarities of the induction immunosuppressive therapy in renal transplantationKeywords
This publication has 46 references indexed in Scilit:
- Cancer risk with alemtuzumab following kidney transplantationClinical Transplantation, 2013
- Alemtuzumab induction in pediatric kidney transplantationPediatric Transplantation, 2013
- Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab InductionAmerican Journal of Nephrology, 2011
- Induction Immunosuppressive Therapy in the Elderly Kidney Transplant Recipient in the United StatesClinical Journal of the American Society of Nephrology, 2011
- Trends in Renal Transplantation in Patients With Human Immunodeficiency Virus Infection: An Analysis of the United States Renal Data SystemTransplantation, 2011
- Impact of Immunosuppressive Regimen on Survival of Kidney Transplant Recipients With Hepatitis CTransplantation, 2008
- T cell subset-specific susceptibility to agingClinical Immunology, 2008
- Induction Therapy in Pediatric Renal Transplant RecipientsPediatric Drugs, 2007
- Influence of polyclonal anti-thymocyte globulins upon ischemia–reperfusion injury in a non-human primate modelTransplant Immunology, 2006
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997